Cancer Research New Funding Opportunities

Fellowship Award

Deadline: August 15, 2025

Amount: $294,000 over four years.

Supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country.

Research Grant: Seed Grant

Deadline: Aug. 15, 2025

Amount: $75,000 over 1 year

Award: Funds research in the following areas: treatment/therapy, patient care, early diagnosis, detection, cancer biology, basic science, prevention/metabolism and research core facilities.\

Please contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Research Grant

Application Deadline: September 3, 2025

Amount: $150,000 over 2 years

Award: The B+ Foundation funds cutting-edge childhood cancer research. The B+ Foundation funds grants that support basic, translational or clinical research, which may lead towards cures and better treatments for childhood cancers. Applicants may be Assistant, Associate or Professor level investigators.

Please contact: Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Global Oncology Young Investigator Award

LOI Deadline: September 11, 2025

Amount: $50,000

Award: Provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. This is a mentored award and the research project is conducted under the guidance of a scientific mentor.

The Global Oncology Young Investigator Award is intended to support:

Research by investigators in low resource settings on scientific questions specific to those settings. This research has potential to offer “reverse innovation” insights that could influence practice in a wide range of practice settings.

Research by investigators in high resource settings on issues in resource-limited settings.
Collaborative research (high and low resource investigators) on questions of shared concern, such as studying a cancer type that affects a small population in the U.S. but is common in another country.

Please contact: Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Young Investigator Award

Application Deadline: September 11, 2025

Amount: $50,000

Award: Provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of these grants is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in the applicable areas of cancer research are accepted from U.S. and international applicants.

Applicants must be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training at an academic medical institution and within 10 years of obtaining their medical degree at the time of grant submission. Examples of subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency.

Please contact: Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Career Development Award

Application Deadline: October 9, 2025

Amount: $200,000 over 3 years

Award: The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Applications in all areas of cancer research are accepted from U.S. and international applicants. Must be in the first to fourth year of a full-time primary faculty appointment.

Please contact: Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu for additional information.

Alex’s Lemonade Stand - Research Accelerating RUNX1 Exploration (RARE) Grant

Deadline: December 11, 2025

Amount: $250,000 over 2 years

Award: The RARE Grant supports research focused on identifying druggable oncogenic pathways and advancing cancer interception and prevention strategies toward clinical application. Funded projects will demonstrate clear potential to benefit patients and families affected by RUNX1-FPD.

Please contact Alex Hood, Associate Director Foundation Relations at alex.hood@bcm.edu with any questions.

Community Grants

Application Deadline: Ongoing until funds are used.

Budget: $20,000-$40,000, for one year.

Award: The Colon Cancer Coalition seeks to provide funds, to liked-minded partners advancing colon cancer research. Funds must be used on programs that will benefit individuals in and around the event city where the money is raised. Priority will be given to programs working to increase screening for adults over 50 to reach the national goal of 80%, patient screening navigation, or addressing young adult onset colorectal cancer.

Contact: Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations at lyndsie.whitehead@bcm.edu for additional information.

Open Proposals Program
Application Deadline: Funding is available on a rolling basis and new grants are awarded frequently.
Budget: $50,000 ~ $828,027, from 6 months to 36 months (average $224,000 for 2 years). NTAP supports indirect costs at a maximum of 10% of direct costs.  

Award: The Johns Hopkins University School of Medicine - Neurofibromatosis Therapeutic Acceleration Program (NTAP) supports research projects designed to accelerate development of effective treatments for NF1 associated peripheral nerve sheath tumors.  NTAP’s Open Proposal program is open to any stage of drug development.  However, proposal must focus on the peripheral nerve tumors of NF1 (Cutaneous, Plexiform and Atypical).

Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations for additional information.